Fig. 6
From: How to prevent viremia rebound? Evidence from a PRRSv data-supported model of immune response
Immune mechanism efficacies discriminating between uniphasic and biphasic viremia profiles. Immune mechanism efficacies discriminating between uniphasic and biphasic viremia profiles. Efficacies of mechanisms known to affect the viral dynamics directly: a cell infection, c-e elimination of infected cells, f neutralisation; or indirectly: b apoptosis of naive target cells. Mean value and standard deviation of the 35 representative individuals selected for the uniphasic (green) and biphasic (red) profiles. ∗p-value <1% when comparing uniphasic and biphasic profiles (Kolmogorov–Smirnov tests over two time periods: 0-20, 21–42 days)